Case: MSP Recovery, Inc.
Contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

NEW YORK, NY – June 2, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of MSP Recovery Inc. ("MSP Recovery” or the "Company”) (NASDAQ: MSPR; MSPRZ), a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery company that purports to use data-driven solutions to secure recoveries against responsible parties for healthcare reimbursement. 

On May 24, 2022, following the completion of a business combination with Lionheart Acquisition Corporation II (“LCAP”), MSP Recovery stock began trading on the NASDAQ.  During trading on May 24, MSP Recovery stock plummeted by over 50% to close at $5.06 per share.

On May 25, 2022, Forbes published an article stating, among other things, that “MSP Recovery’s ‘central tension’ is that it has not litigated its claims and therefore it is difficult to assess its monetary value.  Following this publication shares continued to decline, closing at $3.73 per share.

Then, on May 26, 2022, the Company issued a press release disputing the Forbes article and reaffirming its revenue guidance.  MSP Recovery shares, however, continued to significantly decline in price the remainder of the week to close at $1.74 per share on May 27, 2022.

If you purchased or otherwise acquired shares in MSP Recovery securities and would like to discuss our investigation, please contact us by emailing This e-mail address is being protected from spambots. You need JavaScript enabled to view it or by calling (646) 315-9003.  

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. 

Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com.  If you have any questions about this investigation, your rights, or your interests, please contact: 

Donald R. Hall
KAPLAN FOX & KILSHEIMER LLP
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it